Gut–brain and brain–gut axis in Parkinson's disease models: Effects of a uridine and fish oil diet

Recent investigations have focused on the potential role of gastrointestinal (GI) abnormalities in the pathogenesis of Parkinson's disease (PD). The ‘dual-hit’ hypothesis of PD speculates that a putative pathogen enters the brain via two routes: the olfactory system and the GI system. Here, we investigated (1) whether local exposures of the neurotoxin rotenone in the gut or the brain of mice could induce PD-like neurological and GI phenotypes as well as a characteristic neuropathology in accordance with this ‘dual-hit hypothesis’ and (2) the effects of a diet containing uridine and fish oil providing docosahexaenoic acid (DHA), in both models. Mice were given rotenone either orally or by an injection in the striatum. Dietary interventions were started 1 week before rotenone exposures. We found that (1) both oral and intrastriatal administration of rotenone induced similar PD-like motor deficits, dopaminergic cell loss, delayed intestinal transit, inflammation, and alpha-synuclein accumulation in the colon; (2) the uridine and DHA containing diet prevented rotenone-induced motor and GI dysfunctions in both models. The models suggest possible bidirectional communication between the gut and the brain for the genesis of PD-like phenotype and pathology. The dietary intervention may provide benefits in the prevention of motor and non-motor symptoms in PD.

[1]  C. Pellegrini,et al.  Alteration of colonic excitatory tachykininergic motility and enteric inflammation following dopaminergic nigrostriatal neurodegeneration , 2016, Journal of Neuroinflammation.

[2]  G. O’Keeffe,et al.  Microbiota-gut-brain signalling in Parkinson's disease: Implications for non-motor symptoms. , 2016, Parkinsonism & related disorders.

[3]  Valerio Zerbi,et al.  A Dietary Treatment Improves Cerebral Blood Flow and Brain Connectivity in Aging apoE4 Mice , 2016, Neural plasticity.

[4]  H. Reichmann,et al.  Pathogenesis of Parkinson disease—the gut–brain axis and environmental factors , 2015, Nature Reviews Neurology.

[5]  E. Horváth-Puhó,et al.  Vagotomy and subsequent risk of Parkinson's disease , 2015, Annals of neurology.

[6]  Elliott W. Dirr,et al.  Intrastriatal injection of pre-formed mouse α-synuclein fibrils into rats triggers α-synuclein pathology and bilateral nigrostriatal degeneration , 2015, Neurobiology of Disease.

[7]  L. Leclair-Visonneau,et al.  Enteric glial cells: New players in Parkinson's disease? , 2015, Movement disorders : official journal of the Movement Disorder Society.

[8]  J. Sijben,et al.  A specific multi-nutrient enriched diet enhances hippocampal cholinergic transmission in aged rats , 2015, Neurobiology of Aging.

[9]  Xuemei Huang,et al.  Meta-analyses on prevalence of selected Parkinson’s nonmotor symptoms before and after diagnosis , 2015, Translational Neurodegeneration.

[10]  Jia-Yi Li,et al.  Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats , 2014, Acta Neuropathologica.

[11]  E. Youness,et al.  Effect of a single intrastriatal rotenone injection on oxidative stress and neurodegeneration in the rat brain , 2014, Comparative Clinical Pathology.

[12]  M. Asanuma,et al.  Neuroprotective Effects of Metallothionein Against Rotenone-Induced Myenteric Neurodegeneration in Parkinsonian Mice , 2014, Neurotoxicity Research.

[13]  L. Niles,et al.  Neuroprotection by valproic acid in an intrastriatal rotenone model of Parkinson’s disease , 2014, Neuroscience.

[14]  Valerio Zerbi,et al.  Multinutrient diets improve cerebral perfusion and neuroprotection in a murine model of Alzheimer's disease , 2014, Neurobiology of Aging.

[15]  P. Kamphuis,et al.  Targeting synaptic dysfunction in Alzheimer's disease by administering a specific nutrient combination. , 2013, Journal of Alzheimer's disease : JAD.

[16]  H. Reichmann,et al.  Environmental toxins trigger PD-like progression via increased alpha-synuclein release from enteric neurons in mice , 2012, Scientific Reports.

[17]  T. Dinan,et al.  Mind-altering Microorganisms: the Impact of the Gut Microbiota on Brain and Behaviour , 2022 .

[18]  K. Shannon,et al.  Alpha‐synuclein in colonic submucosa in early untreated Parkinson's disease , 2012, Movement disorders : official journal of the Movement Disorder Society.

[19]  E. Benarroch,et al.  Autonomic involvement in Parkinson's disease: Pathology, pathophysiology, clinical features and possible peripheral biomarkers , 2012, Journal of the Neurological Sciences.

[20]  Jeffrey H. Kordower,et al.  Increased Intestinal Permeability Correlates with Sigmoid Mucosa alpha-Synuclein Staining and Endotoxin Exposure Markers in Early Parkinson's Disease , 2011, PloS one.

[21]  Pablo Martinez-Martin,et al.  The importance of non-motor disturbances to quality of life in Parkinson's disease , 2011, Journal of the Neurological Sciences.

[22]  K. Krogh Gastrointestinal Dysfunction in Parkinson’s Disease , 2011 .

[23]  Honglei Chen,et al.  Original Contribution A Prospective Study of Bowel Movement Frequency and Risk of Parkinson’s Disease , 2011 .

[24]  K. Rea,et al.  Characterisation of a novel model of Parkinson's disease by intra-striatal infusion of the pesticide rotenone , 2011, Neuroscience.

[25]  C. Tanner,et al.  Rotenone, Paraquat, and Parkinson’s Disease , 2011, Environmental health perspectives.

[26]  R. Wurtman,et al.  Nutritional modifiers of aging brain function: use of uridine and other phosphatide precursors to increase formation of brain synapses. , 2010, Nutrition reviews.

[27]  J. Anselmo-Franci,et al.  Evaluation of chronic omega-3 fatty acids supplementation on behavioral and neurochemical alterations in 6-hydroxydopamine-lesion model of Parkinson's disease , 2010, Neuroscience Research.

[28]  H. Braak,et al.  A timeline for Parkinson's disease. , 2010, Parkinsonism & related disorders.

[29]  H. Reichmann,et al.  Progression of Parkinson's Disease Pathology Is Reproduced by Intragastric Administration of Rotenone in Mice , 2010, PloS one.

[30]  L. Montero,et al.  Chronic rotenone exposure reproduces Parkinson's disease gastrointestinal neuropathology , 2009, Neurobiology of Disease.

[31]  S. Srinivasan,et al.  Delayed gastric emptying and enteric nervous system dysfunction in the rotenone model of Parkinson's disease , 2009, Experimental Neurology.

[32]  H. Braak,et al.  Parkinson's Disease , 2009, Annals of the New York Academy of Sciences.

[33]  H. Berendse,et al.  Hyposmia and executive dysfunction as predictors of future Parkinson's disease: A prospective study , 2009, Movement disorders : official journal of the Movement Disorder Society.

[34]  M. Balda,et al.  Tight junctions at a glance , 2008, Journal of Cell Science.

[35]  R. Wurtman,et al.  Restorative effects of uridine plus docosahexaenoic acid in a rat model of Parkinson's disease , 2008, Neuroscience Research.

[36]  R. Wurtman,et al.  Chronic administration of DHA and UMP improves the impaired memory of environmentally impoverished rats , 2008, Behavioural Brain Research.

[37]  F. Cicchetti,et al.  Beneficial effects of dietary omega‐3 polyunsaturated fatty acid on toxin‐induced neuronal degeneration in an animal model of Parkinson's disease , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[38]  M. Maes,et al.  The gut-brain barrier in major depression: intestinal mucosal dysfunction with an increased translocation of LPS from gram negative enterobacteria (leaky gut) plays a role in the inflammatory pathophysiology of depression. , 2008, Neuro endocrinology letters.

[39]  R. Wurtman,et al.  Oral supplementation with docosahexaenoic acid and uridine-5′-monophosphate increases dendritic spine density in adult gerbil hippocampus , 2007, Brain Research.

[40]  H. Braak,et al.  Parkinson's disease: a dual‐hit hypothesis , 2007, Neuropathology and applied neurobiology.

[41]  Pablo Martinez-Martin,et al.  Prevalence of nonmotor symptoms in Parkinson's disease in an international setting; Study using nonmotor symptoms questionnaire in 545 patients , 2007, Movement disorders : official journal of the Movement Disorder Society.

[42]  Kazuyuki Takata,et al.  Neurodegeneration of mouse nigrostriatal dopaminergic system induced by repeated oral administration of rotenone is prevented by 4‐phenylbutyrate, a chemical chaperone , 2007, Journal of neurochemistry.

[43]  W. Koltun,et al.  Loss of the tight junction protein ZO-1 in dextran sulfate sodium induced colitis. , 2007, The Journal of surgical research.

[44]  C. Tanner,et al.  Association of olfactory dysfunction with incidental Lewy bodies , 2006, Movement disorders : official journal of the Movement Disorder Society.

[45]  H. Miwa,et al.  Intragastric proteasome inhibition induces alpha-synuclein-immunopositive aggregations in neurons in the dorsal motor nucleus of the vagus in rats , 2006, Neuroscience Letters.

[46]  M. Cookson,et al.  Intersecting pathways to neurodegeneration in Parkinson's disease: Effects of the pesticide rotenone on DJ-1, α-synuclein, and the ubiquitin–proteasome system , 2006, Neurobiology of Disease.

[47]  H. Braak,et al.  Gastric α-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology , 2006, Neuroscience Letters.

[48]  H. Berendse,et al.  Idiopathic hyposmia as a preclinical sign of Parkinson's disease , 2004, Annals of neurology.

[49]  G. Wooten,et al.  Are men at greater risk for Parkinson’s disease than women? , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[50]  Todd B. Sherer,et al.  Subcutaneous Rotenone Exposure Causes Highly Selective Dopaminergic Degeneration and α-Synuclein Aggregation , 2003, Experimental Neurology.

[51]  C. Tanner,et al.  Frequency of bowel movements and the future risk of Parkinson’s disease , 2001, Neurology.

[52]  A. Bylund-Fellenius,et al.  Experimental colitis induced by dextran sulphate sodium in mice: beneficial effects of sulphasalazine and olsalazine , 1998, Alimentary pharmacology & therapeutics.

[53]  G. C. Wagner,et al.  Uridine reduces rotation induced by l-Dopa and methamphetamine in 6-OHDA-treated rats , 1995, Pharmacology Biochemistry and Behavior.

[54]  P. G. Reeves,et al.  AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. , 1993, The Journal of nutrition.

[55]  H. Gundersen,et al.  Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator , 1991, The Anatomical record.

[56]  H. J. G. GUNDERSEN,et al.  Some new, simple and efficient stereological methods and their use in pathological research and diagnosis , 1988, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[57]  Michaela E Johnson,et al.  An update on the rotenone models of Parkinson's disease: their ability to reproduce the features of clinical disease and model gene-environment interactions. , 2015, Neurotoxicology.

[58]  C. Tanner,et al.  Dietary fat intake, pesticide use, and Parkinson's disease. , 2014, Parkinsonism & related disorders.

[59]  A. Sun,et al.  Oxidative and Inflammatory Pathways in Parkinson’s Disease , 2008, Neurochemical Research.

[60]  M. Beal,et al.  Neuroprotective effects of oral administration of triacetyluridine against MPTP neurotoxicity , 2007, NeuroMolecular Medicine.